New Delhi: India will soon start Phase 2 and 3 trials of Covaxin on children from 2 to 15 years of age.
“Recently, subject expert committee of DCGI gave permission for vaccine trials on children from 2 to 15 years of age to Bharat Biotech. We are waiting for DCGI approval. Hopefully, we will soon start phase 2 and phase 3 trials,” Dr Sanjeev Sinha, Department of Medicine, AIIMS.
The Centre has said the current production capacity of Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-Aug 2021. The production is expected to reach nearly 10 crore doses per month by September 2021, officials said.
Meanwhile, citing the unprecedented rise in Covid cases in the country, the Centre on Wednesday allowed its employees with recognised qualifications to undertake medical practice or teleconsultation.
Such practice is to be undertaken during spare time and on a purely charitable basis, an order issued by the Department of Personnel and…
